Profilo
David Fuller is Chairman at EpiAxis Therapeutics Pty Ltd. since 2020.
Dr. Fuller is Chief Medical Officer at Dimerix Ltd. since 2023.
Former roles include Non-Executive Director at Linear Clinical Research Ltd., Non-Executive Director at AdAlta Ltd. from 2020 to 2026, and Chief Medical Officer at Racura Oncology Ltd. from 2021 to 2022.
Education includes an undergraduate degree from The University of Sydney.
Posizioni attive di David Fuller
| Società | Posizione | Inizio |
|---|---|---|
| DIMERIX LIMITED | Direttore Tecnico/Scientifico/R&S | 01/10/2023 |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Presidente | 01/07/2020 |
Precedenti posizioni note di David Fuller
| Società | Posizione | Fine |
|---|---|---|
| ADALTA LIMITED | Direttore/Membro del Consiglio | 17/04/2026 |
| RACURA ONCOLOGY LTD | Direttore Tecnico/Scientifico/R&S | 11/11/2022 |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Direttore/Membro del Consiglio | - |
Linear Clinical Research Ltd. | Direttore/Membro del Consiglio | - |
Formazione di David Fuller
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
AdAlta Ltd.
AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Linear Clinical Research Ltd. | |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Health Technology |
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Health Technology |
















